Heron Therapeutics, Inc.
USD0.43
-0.00 (-0.18%)
CEO
Craig Alexander Collard
IPO Date
1987-08-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.44
Prev. Close
$0.44
Day Low
$0.43
Day High
$0.45
52W Low
$0.38
52W High
$2.30
Market Cap
$0.07B
Volume
1.31M
| -17.2 |
| 31 Dec 2023 | FY | 48.8% | -87.0% | 325.4% | -49.7% | -5.29 | 2.37 | -2.1 |
| 31 Dec 2022 | FY | 49.0% | -169.1% | -1341.2% | -72.5% | 11.60 | 2.49 | -1.5 |
| 31 Dec 2021 | FY | 46.7% | -255.6% | -284.5% | -72.2% | 2.06 | 3.58 | -4.1 |
| 31 Dec 2020 | FY | 59.2% | -256.4% | -96.1% | -64.3% | 0.10 | 3.07 | -8.5 |
| 31 Dec 2019 | FY | 57.8% | -140.3% | -50.7% | -39.9% | 0.05 | 4.95 | -9.4 |
| 31 Dec 2018 | FY | 64.5% | -230.8% | -48.3% | -38.7% | 0.01 | 4.86 | -10.6 |
| 31 Dec 2017 | FY | 85.1% | -641.9% | -150.6% | -84.3% | 0.22 | 2.21 | -5.0 |
| 31 Dec 2016 | FY | 97.3% | -13537.4% | 814.8% | -256.6% | -2.49 | 1.60 | -2.9 |
| -18.3 |
| 30 Sept 2025 | Q3 | 59.7% | -45.8% | -117.5% | -7.0% | 9.44 | 2.56 | -3.1 |
| 30 Jun 2025 | Q2 | 73.5% | -6.4% | 8.7% | -1.0% | -6.48 | 0.82 | -33.5 |
| 31 Mar 2025 | Q1 | 78.3% | 6.8% | -9.3% | 1.1% | -6.23 | 2.40 | 32.0 |
| 31 Dec 2024 | Q4 | 74.9% | 9.0% | -10.9% | 1.6% | -5.28 | 2.29 | 16.0 |
| 30 Sept 2024 | Q3 | 71.2% | -14.8% | 12.1% | -2.2% | -4.46 | 2.28 | -15.7 |
| 30 Jun 2024 | Q2 | 70.8% | -25.6% | 24.3% | -4.2% | -4.71 | 2.38 | -14.3 |
| 31 Mar 2024 | Q1 | 75.6% | -9.1% | 9.4% | -1.5% | -5.31 | 2.47 | -32.4 |
| 31 Dec 2023 | Q4 | 71.1% | -31.3% | 31.6% | -4.8% | -5.29 | 2.37 | -6.0 |